FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ISOGANCICLOVIR
异名/同义词(+/-)-2-AMINO-9-((2,3-DIHYDROXYPROPOXY)METHYL)-1,9-DIHYDRO-6H-PURIN-6-ONE
(RS)-2-AMINO-9-(2,3-DIHYDROXY-PROPOXYMETHYL)-1,9-DIHYDRO-PURIN-6-ONE
2-AMINO-9-(((2RS)-2,3-DIHYDROXYPROPOXY)METHYL)-1,9-DIHYDRO-6H-PURIN-6-ONE
2-AMINO-9-((2,3-DIHYDROXYPROPOXY)METHYL)-1,9-DIHYDRO-6H-PURIN-6-ONE
3-((2-AMINO-6-HYDROXY-9H-PURIN-9-YL)METHOXY)-1,2-PROPANEDIOL
6H-PURIN-6-ONE, 2-AMINO-9-((2,3-DIHYDROXYPROPOXY)METHYL)-1,9-DIHYDRO-
GANCICLOVIR IMPURITY E [EP IMPURITY]
GANCICLOVIR RELATED COMPOUND A
GANCICLOVIR RELATED COMPOUND A [USP IMPURITY]
GANCICLOVIR RELATED COMPOUND A [USP-RS]
ISOGANCICLOVIR
CAS登记号86357-09-7
物质唯一标识(Unique Ingredient Identifier)NNJ00018WY
分子式C9H13N5O4
国际化合物标识(International Chemical Identifier,InChI)YMJRISBBXAOKCD-UHFFFAOYSA-N
SMILESn1cn(c2nc([nH]c(c12)=O)N)COCC(CO)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 美国药典对照品
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System